Aramark (NYSE:ARMK)
$ 53.93 +0.17 (+0.32%) Market Cap: 14.18 Bil Enterprise Value: 20.19 Bil PE Ratio: 40.25 PB Ratio: 4.32 GF Score: 83/100

Q4 2025 Aramark Earnings Call Transcript

Nov 17, 2025 / 01:30PM GMT
Release Date Price: $36.04 (-5.23%)

Key Points

Positve
  • Aramark (ARMK) achieved annualized gross new wins of $1.6 billion, marking a 12% increase from fiscal '24.
  • The company reported an industry-leading client retention rate of 96.3%, contributing to a net new growth of 5.6%.
  • Aramark (ARMK) expanded its supply chain GPO network with over $1 billion of new purchasing spend for the second consecutive year.
  • The company achieved a leverage ratio of 3.25 times, the lowest since going private in 2007.
  • Aramark (ARMK) reported a 14% increase in organic revenue for the fourth quarter, driven by net new business and base business growth.
Negative
  • The timing shift in new account openings impacted fourth-quarter revenue, as some large client transitions were delayed.
  • Higher incentive-based compensation costs of $25 million were recorded in the fourth quarter, affecting adjusted operating income.
  • The MLB playoffs did not meet expectations, impacting revenue from sports-related services.
  • Aramark (ARMK) faced higher prescription claims and new business start-up costs in the quarter, affecting margins.
  • The company experienced a non-cash asset write-down in the fourth quarter related to a minority interest investment.
Operator

Good morning, and welcome to Aramark's fourth quarter and full year fiscal 2025 earnings results conference call. My name is Kevin, and I'll be your operator for today's call. (Operator Instructions) I will now turn the call over to Felise Kissell, Senior Vice President, Investor Relations and Corporate Development. Ms. Kissell, please proceed.

Felise Kissell
Aramark - Investor Relations and Corporate Affairs

Thank you, and welcome to Aramark's earnings conference call and webcast. This morning, we will be hearing from our CEO, John Zillmer; as well as CFO, Jim Tarangelo. As always, there are accompanying slides for this call that can be viewed through the webcast and are also available on the IR website for easy access.

Our notice regarding forward-looking statements is included in our press release. During this call, we will be making comments that are forward-looking. Actual results may differ materially from those expressed or implied as a result of various risks, uncertainties and important factors, including those discussed in the Risk Factors

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot